To explore the underlying mechanisms by which ALDOA exerts its oncogenic activity in hepatic carcinogenesis, we conducted coimmunoprecipitation (co‐IP) and subsequent mass spectrometry (MS) analyses to identify the interactome of ALDOA in HCC cells (Figure4a; Table S1, Supporting Information). The gene discussed is ALDOA; the disease is hepatocellular carcinoma.